Innovation Pharmaceuticals Reports Enhancements in Manufacture of Brilacidin Phase 3 Drug Supply

NEXT STORY
Precision Therapeutics’ Subsidiary Helomics to Collaborate with Viome to Explore the Impact of the Gut Microbiome on Ovarian Cancer
PREV STORY
T2 Biosystems and Clinicians to Share Clinical Data in Integrated Symposium and Poster Presentations at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cyclacel Pharmaceuticals Announces Proposed Public Offering of Common Stock

author_avatar
NASDAQ Market News

New long-term data confirm Roche’s Gazyva/Gazyvaro extends the lives of people with chronic lymphocytic leukaemia compared to MabThera/Rituxan

After a follow-up time of nearly five years the CLL11 study shows a 51% ...

author_avatar
NASDAQ Market News

Replimune Appoints Tanya Lewis as Chief Development Operations Officer

author_avatar
NASDAQ Market News